Mount Sinai Faces Backlash After Agreeing to Provide Trans Patient Records to Federal Investigators


After Mount Sinai confirmed that a federal grand jury subpoena from the U.S. District Court for the Northern District of Texas sought information on adolescents who received gender-related care, the hospital system faced immediate backlash from families, New York City officials, and LGBTQ+ advocates. The institution said it would notify affected patients as required by New York’s Shield Law, a statute designed to limit out-of-state investigations into lawful reproductive and gender-affirming care.
That acknowledgement, though narrowly framed, intensified Privacy concerns and raised sharp Legal implications for providers operating across conflicting state and federal regimes.
Parents said Mount Sinai staff began calling families on June 4 to warn that transgender children’s medical records might be disclosed to federal investigators. Those calls prompted a news conference outside Mount Sinai West, where parent Dawn Gabriel said her 17-year-old, who’d received two years of gender-affirming care there until February, and other families were “shaking with fear and rage.”
Her statement provided the clearest public account of the immediate human impact: fear that records tied to sensitive treatment could leave New York despite state protections.
Mount Sinai spokeswoman Lucia Lee said the health system remains committed to safeguarding patient privacy. She said that, if disclosure is compelled, Mount Sinai intends to provide only de-identified information. She declined further comment, citing an active legal matter.
That response underscored the hospital’s effort to signal compliance with patient-protection norms while preserving room to navigate federal demands.
Still, the disclosures widened political fallout. City officials and LGBTQ+ advocates described the subpoena as an escalation meant to intimidate transgender youth and their families. They demanded greater transparency about what data federal investigators sought, how Mount Sinai would resist broad requests, and whether existing safeguards are sufficient when federal process collides with shield-law protections and patient trust.
Featured PostsJuly 31, 2026A Guide to Bilateral Orchiectomy as Gender-Affirming Care
News and AdvocacyJuly 30, 2026Artificial Outrage: When Conservatives Use AI to Invent the Trans Threat They Can’t Find
Featured PostsJuly 26, 2026Your Journey from Female to Male: An Introductory Guide to Phalloplasty
Featured PostsJuly 26, 2026When a Child Says They’re Trans: a Deep Dive Into Pediatric Care and Family Decisions